COTE JENNIFER (Interim CFO) received a stock award from HARVARD BIOSCIENCE INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 3/8/2023ACC: 0000921895-23-000667
Officer· Interim CFO
Since Jan 2023
+82.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
82.63K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+26.89K
Price / share
—
Trade value
—
% of position
88.7%
3/6/2023
30.33K→57.23K
Common Stock
Direct
Shares
+25.86K
Price / share
—
Trade value
—
% of position
45.2%
3/6/2023
57.23K→83.09K
Common Stock
Direct
Shares
+29.88K
Price / share
—
Trade value
—
% of position
36.0%
3/6/2023
83.09K→112.97K
Total
Net shares
+82.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2023 | A · Award | +26.89K | — | — | 88.7% | 30.33K | 57.23K |
| Common Stock Direct | 3/6/2023 | A · Award | +25.86K | — | — | 45.2% | 57.23K | 83.09K |
| Common Stock Direct | 3/6/2023 | A · Award | +29.88K | — | — | 36.0% | 83.09K | 112.97K |
| Total | +82.63K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported